Clovis Oncology
CLVS
#10877
Rank
NZ$21.45 M
Marketcap
NZ$0.15
Share price
0.00%
Change (1 day)
-94.96%
Change (1 year)

Clovis Oncology (CLVS) - Cash on Hand

Cash on Hand as of September 2022 : NZ$0.10 Billion

According to Clovis Oncology's latest financial reports the company has NZ$0.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Clovis Oncology - Cash on Hand chart (from 2010 to 2022)

Cash on Hand by year

Year Cash on Hand Change
2021-12-31NZ$0.20 B-36.93%
2020-12-31NZ$0.33 B-24.42%
2019-12-31NZ$0.44 B-43.2%
2018-12-31NZ$0.77 B-2.31%
2017-12-31NZ$0.79 B106.56%
2016-12-31NZ$0.38 B-50.24%
2015-12-31NZ$0.77 B25.37%
2014-12-31NZ$0.61 B56.62%
2013-12-31NZ$0.39 B124.55%
2012-12-31NZ$0.17 B-2.52%
2011-12-31NZ$0.17 B521.71%
2010-12-31NZ$28.9 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$31.39 B 29,440.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$21.31 B 19,958.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$11.97 B 11,163.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$8.90 B 8,276.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$9.05 B 8,418.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
NZ$1.59 B 1,398.64%๐Ÿ‡บ๐Ÿ‡ธ USA